Silver Bullet Therapeutics received two new patents for the OrthoFuzlon Antimicrobial Bone Screw System.
Here are five key notes:
1. Silver Bullet Therapeutics is a privately-held medical device company based in San Jose, Calif. The new patent is for "coating for the controllable release of antimicrobial metal ions" and "bone implant and systems that controllably releases silver."
2. The company expects to make their OrthoFuzlon Antimicrobial Bone Screw System commercially available to select institutions in Europe this fall.
3. The company's approach to adding antimicrobial capabilities to new and existing medical device implants doesn't require external power sources and doesn't use drugs or other pharmaceutical agents.
4. The technology is designed for durability to withstand abrasive forces of screwing into bone.
5. Silver Bullet Therapeutics' IP portfolio is expanding the use of antimicrobial technology on a broad range of medical devices and implants, including orthopedic screws, hip and knee prostheses, cardiac implantable defibrillators and pacemakers.